Results

48 stories for“data centers”

Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.

Mar 13, 2024

Health

Disabled People Report More Climate Harm, Exposing a Planning Blind Spot

New survey analysis points to greater climate-related health harm among disabled people, strengthening the case for accessible alerts, evacuation and cooling plans.

Jul 24, 2026

Health

FDA Grants Accelerated Approval to Rybrevant Faspro for Head and Neck Cancer After Platinum and Immunotherapy

A subcutaneous antibody from Johnson & Johnson becomes the first new option in a decade for people whose recurrent head and neck tumours outlasted standard treatment, with a confirmatory study still owed.

Nov 6, 2026

Health

France’s June Heatwave Toll: 5,764 Excess Deaths in 2026

A delayed mortality count reveals the June heatwave’s true scale, showing why the deadliest climate disaster can pass quietly behind ordinary causes of death.

Jul 23, 2026

Results

Ozempic and Wegovy: What the Trials Actually Showed

Disabled People Report More Climate Harm, Exposing a Planning Blind Spot

FDA Grants Accelerated Approval to Rybrevant Faspro for Head and Neck Cancer After Platinum and Immunotherapy

France’s June Heatwave Toll: 5,764 Excess Deaths in 2026

Results

Ozempic and Wegovy: What the Trials Actually Showed

Disabled People Report More Climate Harm, Exposing a Planning Blind Spot

FDA Grants Accelerated Approval to Rybrevant Faspro for Head and Neck Cancer After Platinum and Immunotherapy

France’s June Heatwave Toll: 5,764 Excess Deaths in 2026